Dimeric prodrug-based nanomedicines for cancer therapy.
Li S, Shan X, Wang Y, Chen Q, Sun J, He Z, Sun B, Luo C.
Li S, et al. Among authors: sun b, sun j.
J Control Release. 2020 Oct 10;326:510-522. doi: 10.1016/j.jconrel.2020.07.036. Epub 2020 Jul 25.
J Control Release. 2020.
PMID: 32721523
Review.